Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis

<div>Increased catalyst activity of XO, originating from pathological and physiological events. Involvement of XO in pathophysiological processes suggests applications of XO inhibitors to the treatment of various disorders.</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis 

Figure 4 | Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis 